CHF6001 DPI
CLI-06001AC1-01
Phase 2 small_molecule active
Quick answer
CHF6001 DPI for Asthma is a Phase 2 program (small_molecule) at Chiesi Farmaceutici S.p.A with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chiesi Farmaceutici S.p.A
- Indication
- Asthma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active